Aldosterone promotes atrial fibrillation

European Heart Journal

Volumn 33, Issue 16, 2012, Pages 2098-2108

  Reil, Jan Christian ^a   Hohl, Mathias ^a   Selejan, Simina ^a   Lipp, Peter ^b   Drautz, Fabian ^a   Kazakow, Andrey ^a   Münz, Benedikt M ^a   Müller, Patrick ^a   Steendijk, Paul ^c   Reil, Gert Hinrich ^d   Allessie, Maurits A ^e   Böhm, Michael ^a   Neuberger, Hans Ruprecht ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d KLINIKUM OLDENBURG   (Germany)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Aldosterone; Atrial conduction disturbances; Atrial fibrillation; Structural remodelling; Ventricular function

Indexed keywords

ALDOSTERONE; COLLAGEN; COLLAGENASE 3; CONNEXIN 43;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; FIBROBLAST; HEART ATRIUM FIBRILLATION; HEART ATRIUM PRESSURE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART RIGHT ATRIUM; IN VIVO STUDY; NONHUMAN; P WAVE; PRIORITY JOURNAL; RAT;

ALDOSTERONE; ANIMALS; ATRIAL FIBRILLATION; CONNEXIN 43; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FIBROSIS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HEART ATRIA; HEART CONDUCTION SYSTEM; HEMODYNAMICS; HYPERALDOSTERONISM; MATRIX METALLOPROTEINASE 13; MYOCYTES, CARDIAC; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84865259929     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr266     Document Type: Article

References (31)

1. Neuberger HR, Mewis C, van Veldhuisen DJ, Schotten U, van Gelder IC, Allessie MA, Böhm M. Management of atrial fibrillation in patients with heart failure. Eur Heart J 2007;28:2568-2577.
2. Nattel S. Atrial electrophysiology and mechanisms of atrial fibrillation. J Cardiovasc Pharmacol Ther 2003;19:1393-1404.
3. Allessie MA, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-246.
4. Werner CM, Böhm M. The therapeutic role of RAS blockade in chronic heart failure. Ther Adv Cardiovasc Dis 2008;2:215-223.
5. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005;45:1243-1248.
6. Tsai C-T, Chiang FT, Tseng C-D, Hwang JJ, Kuo KT, Wu CK, Yu CC, Wang YC, Lai LP, Jan JL. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation. J Am Coll Cardiol 2010;55: 758-770.
7. Sun Y, Ramires FJA, Weber KT. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovas Res 1997;35:138-147.
8. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990;67:1355-1364.
9. Milliez P, Deangelis N, Rucker-Martin C, Leenhardt A, Vicaut E, Robidel E, Beaufils P, Delcayre C, Hatem SN. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. Eur Heart J 2005;26: 2193-2199.
10. Reil JC, Hohl M, Oberhofer M, Kazakov A, Kaestner L, Mueller P, Adam O, Maack C, Lipp P, Mewis C, Allessie M, Laufs U, Böhm M, Neuberger HR. Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodeling. Cardiovas Res 2010;87:485-93.
11. Reil JC, Gilles S, Zahler S, Brandl A, Drexler H, Hültner L, Matrisian LM, Welsch U, Becker BF. Insights from knock-out models concerning postischemic release of TNFa from isolated mouse hearts. J Mol Cell Cardiol 2007;42:133-142.
12. Verheule S, Sato T, Olgin JE. Atrial fibrillation. A Handbook of Mouse Models of Cardiovascular Disease, Chapter 28. London: John Wiley and Sons; 2006. p351-364.
13. Konings KT, Kirchhof CJ, Smeets JR, Wellens HJ, Penn OC, Allessie MA. High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994;89:1665-1680.
14. Neuberger HR, Schotten U, Verheule S, Eijsbouts S, Blaauw Y, van Hunnik A, Allessie MA. Development of a substrate of atrial fibrillation during chronic atrio-ventricular block in the goat. Circulation 2005;111:30-37.
15. Carmeliet E, Vereecke J. General description of electrical activity. In: Carmeliet E, Vereecke J, eds. Cardiac Cellular Electrophysiology. Boston, Dordrecht/London: Kluwer Academic Publishers Group; 2002. p1-7.
16. Goette A, Hoffmanns P, Enayati W, Meltendorf U, Geller JC, Klein HU. Effect of successful electrical cardioversion on serum aldosterone in patients with persistent atrial fibrillation. Am J Cardiol 2001;88:906-909.
17. Shroff SC, Ryu K, Martovitz NL, Hoit BD, Stambler BS. Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure. J Cardiovasc Electro-physiol 2006;17:534-541.
18. Gao X, Peng L, Adhikari CM, Lin J, Zuo Z. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J Card Fail 2007;13:170-177.
19. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs. Circulation 1999;100:87-95.
20. Cohn JN, Anand IS, Latini R, Masson S, Chiang YT, Glazer R, Valsartan Heart Failure Trial Investigators. Sustained reduction of aldosterone in response to the angiotensin receptor blocker valsartan in patients with chronic heart failure: results from the Valsartan Heart Failure Trial. Circulation 2003;108:1306-1309.
21. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003;107:714-720.
22. Borlaug B, Lam CS, Roger VL, Rodeheffer RJ, Redfield MM. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogen-esis of heart failure with preserved ejection fraction. J Am Coll Cardiol 2009;54: 410-418.
23. van Heerebeek L, Borbély A, Niessen HWM, Bronzwaer JGF, van der Velden J, Stienen GJM, Linke WA, Laarman GJ, Paulus WJ. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006;113:1966-1973.
24. Diez J, Querejeta R, Lopez B, Gonzalez A, Larman M, Martinez Ubago JL. Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients. Circulation 2002;105: 2512-2517.
25. Kindermann M, Reil JC, Pieske B, von Veldhuisen DJ, Böhm M. Heart failure with normal left ventricular ejection fraction: what is the evidence? Trends Cardiovasc Med 2008;18:280-292.
26. Kleber AG, Rudy Y. Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev 2004;84:431-88.
27. Eijsbouts SCM, Majidi M, van Zandvoort M, Allessie MA. Effects of acute atrial dilatation on heterogeneity in conduction in the isolated rabbit heart. J Cardiovasc Electrophysiol 2003;14:269-278.
28. Sanders P, Morton JB, Davidson NC, Spence SJ, Vohra JK, Sparks PB, Kalman JM. Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans. Circulation 2003;108:1461-1468.
29. Rucker-Martin C, Milliez P, Tan A, Decrouy X, Recouvreur M, Vrancks R, Delayre C, Renaud J-F, Dunia I, Segretain D, Hatem SN. Chronic hemodynamic overload of the atria is an important factor for gap junction remodeling in human and rat hearts. Cardiovasc Res 2006;72:69-79.
30. Burstein B, Comtois P, Michael G, Nishida K, Villeneuve L, Yeh YH, Nattel S. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure. Circ Res 2009;105:1213-1222.
31. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995;92: 1954-1968.